Blood test spots overdose patients at risk of liver damage

November 13, 2017
Credit: CC0 Public Domain

People who overdose on paracetamol could be helped by a blood test that shows immediately if they are going to suffer liver damage.

Researchers say the test - which detects levels of specific molecules in blood - will help doctors identify which patients arriving in need more intense .

It will also help speed the development of new therapies for by targeting patients most likely to benefit.

The test detects three different molecules in the blood that are associated with liver damage - called miR-122, HMGB1 and FL-K18.

Previous studies have shown that levels of these markers are elevated in patients with liver damage long before current tests can detect a problem.

A team led by the Universities of Edinburgh and Liverpool measured levels of the three markers in more than 1000 patients across the UK who needed hospital treatment for overdose.

They found that the test can accurately predict which patients are going to develop , and who may need to be treated for longer before they are discharged.

The test could also help identify patients who can be safely discharged after treatment, helping to free up hospital beds.

Paracetamol is a relatively safe painkiller when taken at the right dose. Around 50,000 people are admitted to hospital each year in the UK due to overdose, however.

Many people unknowingly consume too much by taking paracetamol at the same time as cold and flu medications that also contain the drug.

Liver injuries are a common complication of drug overdoses. In some cases the damage can be so severe that the patient needs a transplant and, in rare instances, can be fatal.

Patients with a life-threatening level of paracetamol in their blood can be treated with an antidote called acetylcysteine, given by intravenous drip. The treatment is associated with side effects so doctors do not treat patients longer than necessary.

The researchers say the could help to pinpoint who are unlikely to benefit from treatment.

The study, published in The Lancet Gastroenterology & Hepatology, was funded by the Edinburgh and Lothians Health Foundation and the Medical Research Council.

Dr James Dear, of the University of Edinburgh, said: "Paracetamol is very common and presents a large workload for already over-stretched Emergency Departments. These new blood tests can identify who will develop liver injury as soon as they first arrive at hospital. This could transform the care of this large, neglected, patient group."

Dr Daniel Antoine, who was based at the University of Liverpool during the study but is now at the University of Edinburgh, said: "This is an excellent example of scientists, clinicians and statisticians working together to tackle an important medical problem. The outcome of studies like these have generated excitement amongst the pharmaceutical industry and drug regulation so that we can further our understanding of the fundamental basis of drug-induced injury."

Explore further: Predicting liver injury in paracetamol overdose patients

More information: The Lancet Gastroenterology & Hepatology, DOI: 10.1016/S2468-1253(17)30266-2

Related Stories

Predicting liver injury in paracetamol overdose patients

February 22, 2013
Scientists at the University of Liverpool have identified molecules in the blood that could help predict the risk of a patient developing liver injury eight hours after a paracetamol overdose.

Paracetamol: Repeated ingestion of slightly too much can be fatal -- recognize and treat quickly

November 23, 2011
Repeatedly taking slightly too much paracetamol over time can cause a dangerous overdose that is difficult to spot, but puts the person at danger of dying. Patients may not come to hospital reporting the overdose, but because ...

Paracetamol study could open door for way to treat liver damage

January 31, 2017
Scientists have shed new light on how the common painkiller paracetamol causes liver damage.

Paracetamol poisoning treatment guidelines costing NHS millions

March 26, 2014
Strict guidelines for treating paracetamol overdoses – introduced 18 months ago – are costing the NHS millions of pounds a year, researchers claim.

Stopping liver failure from painkiller overdose

February 3, 2014
(Medical Xpress)—University of Adelaide researchers have identified a key step for the future prevention of liver failure resulting from taking too much of the everyday painkiller paracetamol (also known as acetaminophen).

Recommended for you

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.